U.S. Markets close in 3 mins

CONMED Corporation (CNMD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
136.37+2.12 (+1.58%)
As of 3:57PM EDT. Market open.

CONMED Corporation

11311 Concept Boulevard
Largo, FL 33773-4908
United States
727 392 6464

IndustryMedical Devices
Full Time Employees3,400

Key Executives

NameTitlePayExercisedYear Born
Mr. Curt R. HartmanChairman, CEO & Pres1.79M9.01M1964
Mr. Todd W. GarnerExec. VP & CFO826.5kN/A1969
Mr. John E. KennedyGroup Exec. VP of Advanced Endoscopic Technologies572.93k968.73k1958
Mr. Patrick J. BeyerPres of International & Global Orthopedics932.46kN/A1966
Mr. Stanley W. Peters IIIVP & GM of U.S. Advanced Surgical620.75k957.42k1975
Mr. Daniel S. JonasExec. VP of Legal Affairs, Gen. Counsel & Sec.N/AN/A1964
Mr. Peter K. ShagoryExec. VP of Strategy & Corp. Devel.N/AN/A1969
Ms. Heather L. CohenExec. VP of HRN/AN/A1973
Ms. Shanna L. Cotti-OsmanskiExec. VP of Information Technology & CION/AN/A1977
Mr. David R. MurrayPres of ConMed ElectrosurgeryN/AN/A1948
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Corporate Governance

CONMED Corporation’s ISS Governance QualityScore as of June 1, 2021 is 2. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 2; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.